Cargando…
A Randomised, Blinded, Placebo-Controlled Trial in Dementia Patients Continuing or Stopping Neuroleptics (The DART-AD Trial)
BACKGROUND: There have been increasing concerns regarding the safety and efficacy of neuroleptics in people with dementia, but there are very few long-term trials to inform clinical practice. The aim of this study was to determine the impact of long-term treatment with neuroleptic agents upon global...
Autores principales: | Ballard, Clive, Lana, Marisa Margallo, Theodoulou, Megan, Douglas, Simon, McShane, Rupert, Jacoby, Robin, Kossakowski, Katja, Yu, Ly-Mee, Juszczak, Edmund |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2276521/ https://www.ncbi.nlm.nih.gov/pubmed/18384230 http://dx.doi.org/10.1371/journal.pmed.0050076 |
Ejemplares similares
-
Cost‐effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO‐AD trial)
por: Knapp, Martin, et al.
Publicado: (2016) -
Barriers to stopping neuroleptic (antipsychotic) treatment in
people with schizophrenia, psychosis or bipolar
disorder
por: Moncrieff, Joanna, et al.
Publicado: (2020) -
DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease – a multicentre RCT
por: Jones, Rob, et al.
Publicado: (2009) -
Dart in action
por: Buckett, Chris
Publicado: (2013) -
What is Dart?
por: Walrath, Kathy, et al.
Publicado: (2012)